Sort
30,917 grants matching “tumor microenvironment”
Project 2: Optimal Targeting of the PD-1/PD-L1 Pathway in MRCC
$284,060Catherine Ju-Ying Wu · Beth Israel Deaconess Medical Center · P50 · FY2021 · CA
Molecular Imaging of Chemokine Receptor Signaling
$284,011Gary D Luker · University Of Michigan At Ann Arbor · R01 · FY2013 · CA
Glaucoma, Neurotrophins, and the Lamina Cribrosa
$284,000University Of North Texas Hlth Sci Ctr · R01 · FY2002 · EY
Glaucoma, Neurotrophins, and the Lamina Cribrosa
$284,000University Of North Texas Hlth Sci Ctr · R01 · FY2003 · EY
Targeting Mechanisms of Endocrine Resistance in Breast Cancer
$283,987Myles A Brown · Dana-Farber Cancer Inst · P01 · FY2024 · CA
Developing Multi-Genic Anti-Breast Cancer Therapies
$283,865Robert J Debs · California Pacific Med Ctr Res Institute · R01 · FY2008 · CA
Developing Multi-Genic Anti-Breast Cancer Therapies
$283,865Robert J Debs · California Pacific Med Ctr Res Institute · R01 · FY2007 · CA
Developing Multi-Genic Anti-Breast Cancer Therapies
$283,865Robert J Debs · California Pacific Med Ctr Res Institute · R01 · FY2009 · CA
Role of Bim in mediating CAM-DR in hematopoietic tumors
$283,860Lori A Hazlehurst · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Role of Bim in mediating CAM-DR in hematopoietic tumors
$283,860Lori A Hazlehurst · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Enhancing the efficacy of CD19-specific cord blood-derived T Cells
$283,822Laurence J.n. Cooper · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Imaging of Stromal Cells in the Tumor Microenvironment
$283,740Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2006 · CA
Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer
$283,715Ellen Pure' · Wistar Institute · R01 · FY2013 · CA
Project 4. Targeting genomic instability and evolution in myeloma
$283,713Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2017 · CA
Correction of dendritic cells defects in cancer
$283,694Dmitry Isaac Gabrilovich · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Combination Therapy of OvCA with Oligonucleotides and Photodynamic Therapy
$283,650Xin Ming · Wake Forest University Health Sciences · R01 · FY2018 · CA
Combination Therapy of OvCA with Oligonucleotides and Photodynamic Therapy
$283,650Xin Ming · Wake Forest University Health Sciences · R01 · FY2017 · CA
Combination Therapy of OvCA with Oligonucleotides and Photodynamic Therapy
$283,650Xin Ming · Wake Forest University Health Sciences · R01 · FY2020 · CA
TARGETING MYCN PROTEIN WITH SMALL MOLECULES
$283,648William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2011 · CA
PDX tumor-TME acquired resistance
$283,621Jack Roth · University Of California, San Francisco · U54 · FY2023 · CA
Activatable MR Imaging Probes
$283,594Peter D Caravan · Massachusetts General Hospital · R01 · FY2011 · CA
Tumor Necrosis Factor Modulation of CPCs
$283,591Sumanth D Prabhu · University Of Louisville · P01 · FY2015 · HL
10X Chromium Connect for Single Cell Library Preparations for Translational Research
$283,500Judith A. Varner · University Of California, San Diego · S10 · FY2022 · OD
Novel Targets/Protection of T Cells From Tumor-Induced
$283,483University Of Pittsburgh At Pittsburgh · R01 · FY2005 · CA
Project 3: Prostatic Epithelial Stromal Interactions Facilitate Bone Metastasis
$283,400Neil A Bhowmick · Cedars-Sinai Medical Center · P01 · FY2017 · CA